The growth of the Point of Care Diagnostics market is mainly attributed to the introduction of new devices to perform molecular testing… Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in 3 minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Such advancements in new launched devices will propel the overall POC market growth during the forecast period.
Get Sample Report At: https://www.theinsightpartners.com/sample/TIPRE00006394/
The global point of care diagnostics market is US$ 26.60 Bn in 2018 and is predicted to grow at a CAGR of 11.8% during the forecast period 2019 – 2027, to reach US$ 70.89 Bn by 2027.
The number of point-of-care testing (POCT) has steadily increased over the last 40 years since it’s been widespread introduction. Growth of point of care market is likely to proceed with the help of the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance.
Company Profiles
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Bio Rad Laboratories Inc.
• Abbott
• bioMérieux SA
• Johnson & Johnson Services, Inc.
• Nova Biomedical
• Siemens AG
• BD
• PTS Diagnostics
POINT OF CARE DIAGNOSTICS – MARKET SEGMENTATION
BY PRODUCT
• Glucose Monitoring
• Infectious Disease Testing
o HIV Testing Products
o Influenza Testing Products
o Sexually Transmitted Disease (STD) Testing Products
o Hepatitis C Testing Products
o Healthcare-Associated Infection (HAI) Testing Products
o Tropical Disease Testing Products
o Respiratory Infection Testing Products
o Other Infectious Disease Testing Products
• Cardiometabolic Testing
• Pregnancy And Fertility Testing
• Coagulation Testing
• Tumor/Cancer Marker Testing
• Cholesterol Testing
• Urinalysis Testing
• Hematology Testing
• Other POC Products
BY PRESCRIPTION MODE
• Prescription-Based Testing
• OTC Testing
BY END USER
• Professional Diagnostic Centers
• Home Care
• Research Laboratories
• Others
BY GEOGRAPHY
• North America
o U.S.
o Canada
o Mexico
• Europe
o France
o Germany
o UK
o Spain
o Italy
• Asia Pacific (APAC)
o China
o India
o Japan
o Australia
o South Korea
• Middle East & Africa (MEA)
o Saudi Arabia
o South Africa
o UAE
• South and Central America
o Brazil
o Argentina
The global point of care diagnostics market by product was led by glucose monitoring products segment. In 2018, the glucose monitoring products segment held a largest market share of the point of care diagnostics market. This segment is also expected to dominate the market in 2027 owing to the increasing diabetic patients. However, infectious disease testing product market is expected to grow at significant rate in the forecast period. Moreover, Infectious disease rapid test kits are widely available for a wide variety of prophlogistic pathogen targets, including bacterial, viral, fungal, protozoan, and other disease agents.
About Us:-
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact us:-
The Insight partners,
Phone: +1-646-491-9876
Email: [email protected]
Website: www.theinsightpartners.com
